Related Experiment Video

Updated: Aug 17, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K

Severe community-acquired pneumonia

Michael S Niederman1,2, Antoni Torres3,2

  • 1Division of Pulmonary and Critical Care Medicine, New York Presbyterian/Weill Cornell Medical Center, Weill Cornell Medical College, New York, NY, USA.

European Respiratory Review : an Official Journal of the European Respiratory Society
|December 14, 2022
PubMed

Insights

This review clarifies controversies in severe community-acquired pneumonia (SCAP) management. It discusses diagnostic techniques, treatment durations, and adjunctive therapies for better patient outcomes in critical respiratory infections.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Severe community-acquired pneumonia (SCAP) presents significant morbidity and mortality, necessitating optimized clinical strategies.
  • Current management guidelines for SCAP involve several areas of ongoing clinical debate and research.
  • Understanding these controversies is crucial for improving patient care and reducing mortality rates.

Approach:

  • This review synthesizes current evidence on six controversial aspects of SCAP management.
  • It critically evaluates diagnostic methods, therapeutic choices, and adjunctive treatments.
  • The focus is on providing an in-depth analysis of unresolved issues in SCAP.

Key Points:

  • Controversies include the utility of PCR for microbial diagnosis and the role of biomarkers.
  • Debates persist regarding optimal antibiotic choices (macrolides vs. quinolones), treatment duration, and the use of prediction scores for drug-resistant pathogens.
  • The application of noninvasive ventilation, high-flow nasal oxygen, and adjunctive corticosteroids in SCAP management are also discussed.

Conclusions:

  • Resolving these controversies through further research is essential for refining SCAP treatment protocols.
  • Evidence-based decisions on diagnostics and therapeutics can significantly impact patient outcomes.
  • This review highlights critical areas for future investigation to advance the management of severe pneumonia.

More Related Videos

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.1K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.1K

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
300
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
344
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
421
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
418
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.3K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
314